Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Castillo

Showing results (1201-1210 of 1,342) with videos related to

Pageof 135
Sort By:
Biorxiv : the Preprint Server for Biology|August 30, 2023
<i>Prevotella copri</i>-related effects of a therapeutic food for malnutritionHao-Wei Chang, Evan M Lee, Yi Wang, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 21, 2023
Zanubrutinib Versus Ibrutinib in Symptomatic Waldenström Macroglobulinemia: Final Analysis From the Randomized Phase III ASPEN StudyMeletios A Dimopoulos, Stephen Opat, Shirley D'Sa, et al.
American Journal of Hematology|April 7, 2017
IgM myeloma: A multicenter retrospective study of 134 patientsJorge J Castillo, Artur Jurczyszyn, Lucie Brozova, et al.
JCO Global Oncology|July 16, 2021
Real-World Data on Adult T-Cell Leukemia/Lymphoma in Latin America: A Study From the Grupo de Estudio Latinoamericano de LinfoproliferativosLuis Malpica, Daniel J Enriquez, Denisse A Castro, et al.
Clinical Rheumatology|December 12, 2018
Pulmonary hypertension in Spanish patients with systemic sclerosis. Data from the RESCLE registryFrancisco J García-Hernández, María J Castillo-Palma, Carles Tolosa-Vilella, et al.
Journal of the National Comprehensive Cancer Network : JNCCN|January 20, 2024
Waldenström Macroglobulinemia/Lymphoplasmacytic Lymphoma, Version 2.2024, NCCN Clinical Practice Guidelines in OncologyShaji K Kumar, Natalie S Callander, Kehinde Adekola, et al.
Blood|February 11, 2026
Evolution of tumor subclones and T-cell dynamics underlie variable ibrutinib responses in Waldenström macroglobulinemiaHao Sun, Romanos Sklavenitis Pistofidis, Shirong Liu, et al.
Neurology|September 10, 2010
Prior antiplatelet therapy and outcome following intracerebral hemorrhage: a systematic reviewB B Thompson, Y Béjot, V Caso, et al.
Nature Microbiology|March 20, 2024
Prevotella copri and microbiota members mediate the beneficial effects of a therapeutic food for malnutritionHao-Wei Chang, Evan M Lee, Yi Wang, et al.
Blood Advances|February 5, 2024
Biomarker analysis of the ASPEN study comparing zanubrutinib with ibrutinib for patients with Waldenström macroglobulinemiaConstantine S Tam, Stephen Opat, Shirley D'Sa, et al.
Pageof 135

Showing results (1201-1210 of 1,342) with videos related to

Sort By:
Pageof 135
Biorxiv : the Preprint Server for Biology|August 30, 2023
<i>Prevotella copri</i>-related effects of a therapeutic food for malnutritionHao-Wei Chang, Evan M Lee, Yi Wang, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 21, 2023
Zanubrutinib Versus Ibrutinib in Symptomatic Waldenström Macroglobulinemia: Final Analysis From the Randomized Phase III ASPEN StudyMeletios A Dimopoulos, Stephen Opat, Shirley D'Sa, et al.
American Journal of Hematology|April 7, 2017
IgM myeloma: A multicenter retrospective study of 134 patientsJorge J Castillo, Artur Jurczyszyn, Lucie Brozova, et al.
JCO Global Oncology|July 16, 2021
Real-World Data on Adult T-Cell Leukemia/Lymphoma in Latin America: A Study From the Grupo de Estudio Latinoamericano de LinfoproliferativosLuis Malpica, Daniel J Enriquez, Denisse A Castro, et al.
Clinical Rheumatology|December 12, 2018
Pulmonary hypertension in Spanish patients with systemic sclerosis. Data from the RESCLE registryFrancisco J García-Hernández, María J Castillo-Palma, Carles Tolosa-Vilella, et al.
Journal of the National Comprehensive Cancer Network : JNCCN|January 20, 2024
Waldenström Macroglobulinemia/Lymphoplasmacytic Lymphoma, Version 2.2024, NCCN Clinical Practice Guidelines in OncologyShaji K Kumar, Natalie S Callander, Kehinde Adekola, et al.
Blood|February 11, 2026
Evolution of tumor subclones and T-cell dynamics underlie variable ibrutinib responses in Waldenström macroglobulinemiaHao Sun, Romanos Sklavenitis Pistofidis, Shirong Liu, et al.
Neurology|September 10, 2010
Prior antiplatelet therapy and outcome following intracerebral hemorrhage: a systematic reviewB B Thompson, Y Béjot, V Caso, et al.
Nature Microbiology|March 20, 2024
Prevotella copri and microbiota members mediate the beneficial effects of a therapeutic food for malnutritionHao-Wei Chang, Evan M Lee, Yi Wang, et al.
Blood Advances|February 5, 2024
Biomarker analysis of the ASPEN study comparing zanubrutinib with ibrutinib for patients with Waldenström macroglobulinemiaConstantine S Tam, Stephen Opat, Shirley D'Sa, et al.
Pageof 135